Market closed
Inovio Pharmaceuticals/$INO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inovio Pharmaceuticals
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Ticker
$INO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
134
ISIN
US45773H4092
Website
INO Metrics
BasicAdvanced
$67M
-
-$3.95
0.92
-
Price and volume
Market cap
$67M
Beta
0.92
52-week high
$13.44
52-week low
$1.42
Average daily volume
599K
Financial strength
Current ratio
2.769
Quick ratio
2.698
Long term debt to equity
13.675
Total debt to equity
17.32
Interest coverage (TTM)
-632.05%
Management effectiveness
Return on assets (TTM)
-49.45%
Return on equity (TTM)
-115.42%
Valuation
Price to revenue (TTM)
227.018
Price to book
0.96
Price to tangible book (TTM)
0.96
Price to free cash flow (TTM)
-0.473
Growth
Revenue change (TTM)
-73.83%
Earnings per share change (TTM)
-35.20%
3-year revenue growth (CAGR)
-50.31%
3-year earnings per share growth (CAGR)
-39.06%
What the Analysts think about INO
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inovio Pharmaceuticals stock.
INO Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
INO Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
INO News
AllArticlesVideos
Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)
Seeking Alpha·5 hours ago
Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript)
Seeking Alpha·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inovio Pharmaceuticals stock?
Inovio Pharmaceuticals (INO) has a market cap of $67M as of May 10, 2025.
What is the P/E ratio for Inovio Pharmaceuticals stock?
The price to earnings (P/E) ratio for Inovio Pharmaceuticals (INO) stock is 0 as of May 10, 2025.
Does Inovio Pharmaceuticals stock pay dividends?
No, Inovio Pharmaceuticals (INO) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Inovio Pharmaceuticals dividend payment date?
Inovio Pharmaceuticals (INO) stock does not pay dividends to its shareholders.
What is the beta indicator for Inovio Pharmaceuticals?
Inovio Pharmaceuticals (INO) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.